SEC reporting owner

Cormorant Private Healthcare Fund II, LP SEC insider disclosures

Explore Cormorant Private Healthcare Fund II, LP's reporting-owner identity, issuer relationships, purchases, sales and SEC filing receipts.

As of 2026-10-07T00:29:11.873Z

Reporting owner CIK
0001747677
Issuers
12
Coverage
verified

Inspect this reporting owner's activity

Step 1 of 3

Recent SEC transactions

Cormorant Private Healthcare Fund II, LP: source evidence dated 2026-10-07T00:29:11.873Z.

Publicly available
2025-10-02
Trade date
2025-09-30
Issuer ticker
MLTX
Code
S
Shares
5,827
Reported value
Not reported
What you should see

The displayed owner or issuer and source fields identify the receipt to verify; keep reporting and availability dates separate.

Step 2 of 3

Which issuer and transaction does this person appear in?

Match the reviewed owner identity, issuer and transaction code. Directory eligibility does not turn every filing into a strategy signal.

SEC accession 0000929638-25-003712
What you should see

Use the linked SEC receipts and company profiles to verify what became public and when.

Step 3 of 3

Browse insider directory

Use the linked SEC receipts and company profiles to verify what became public and when.

Browse insider directory
What you should see

Keep reporting dates and units beside the answer, and inspect its original citations.

Issuer relationships

A reporting-owner CIK identifies the filer across issuer relationships and name aliases. A filer may be an individual or an organization; the filing role is the relevant evidence.

Avidity Biosciences, Inc.0001599901RNANoNo
Akouos, Inc.0001722271AKUSNoNo
Atea Pharmaceuticals, Inc.0001593899AVIRNoNo
Olema Pharmaceuticals, Inc.0001750284OLMANoNo
BioAtla, Inc.0001826892BCABNoNo
Design Therapeutics, Inc.0001807120DSGNNoNo
Rain Therapeutics Inc.0001724979RAINNoNo
Monte Rosa Therapeutics, Inc.0001826457GLUENoNo
Aerovate Therapeutics, Inc.0001798749AVTENoNo
Erasca, Inc.0001761918ERASNoYes
GreenLight Biosciences Holdings, PBC0001822691GRNANoNo
MoonLake Immunotherapeutics0001821586MLTXNoNo

Recent SEC transactions

See the complete recent sec transactions

Code P identifies a purchase, S a sale and A an award. Awards and open-market purchases describe different events. Use the public availability date when deciding when a researcher could have known about the transaction.

2025-10-022025-09-30MLTXS5,827Not reported
2025-10-022025-09-29MLTXS2,800,000Not reported
2025-10-022025-09-29MLTXS3,390,943Not reported
2025-10-022025-09-29MLTXS232,460Not reported
2025-10-022025-09-29MLTXS70,748Not reported

Up to 50 transactions from the recent two-year owner window.

Source evidence and strategy eligibility

The transactions below come from filings; a historical tracker separately simulates following eligible events. Joint filers can report the same transaction, and an owner can have filings at multiple companies. Public availability, amendment lineage and verified coverage determine which events a historical tracker may use.

The current directory marks this owner's filing coverage verified.

Aurora · AI research assistant

Try this in Aurora

Edit the request, then open it in Aurora. You choose when to send it.